Quoin Pharmaceuticals, Ltd.QNRX
NASDAQ > Biotechnology
DCF:$2.66 | P/E: -
$0.07(-11.30%)
Change Rating:
Price: $0.569 USD
Market Cap: $2.55M
...Loading QNRX Peers...
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
4 Employees
CEO : Dr. Michael Myers Ph.D.
Address : 42127 Pleasant Forest Court, Ashburn,VA, US, - 20148-7349,
Key Excutives | Designation |
---|---|
Dr. Michael Myers Ph.D. | Co-Founder, Chief Executive Officer & Chairman |
Mr. Gordon Bruce Dunn J.D. | Chief Financial Officer |
Ms. Denise Carter | Co-Founder, Chief Operating Officer & Director |